ResMed (NYSE:RMD) Now Covered by Morgan Stanley
Morgan Stanley began coverage on shares of ResMed (NYSE:RMD – Free Report) in a research note issued to investors on Wednesday, MarketBeat reports. The firm issued an overweight rating and a $280.00 ...